186 related articles for article (PubMed ID: 11382538)
1. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls.
Steel RM; Bastin ME; McConnell S; Marshall I; Cunningham-Owens DG; Lawrie SM; Johnstone EC; Best JJ
Psychiatry Res; 2001 May; 106(3):161-70. PubMed ID: 11382538
[TBL] [Abstract][Full Text] [Related]
2. Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls.
Tang CY; Friedman J; Shungu D; Chang L; Ernst T; Stewart D; Hajianpour A; Carpenter D; Ng J; Mao X; Hof PR; Buchsbaum MS; Davis K; Gorman JM
BMC Psychiatry; 2007 Jun; 7():25. PubMed ID: 17578565
[TBL] [Abstract][Full Text] [Related]
3. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
6. White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study.
Schlösser RG; Nenadic I; Wagner G; Güllmar D; von Consbruch K; Köhler S; Schultz CC; Koch K; Fitzek C; Matthews PM; Reichenbach JR; Sauer H
Schizophr Res; 2007 Jan; 89(1-3):1-11. PubMed ID: 17085018
[TBL] [Abstract][Full Text] [Related]
7. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
Deicken RF; Johnson C; Pegues M
Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
[TBL] [Abstract][Full Text] [Related]
9. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
10. A diffusion tensor imaging study of fasciculi in schizophrenia.
Shergill SS; Kanaan RA; Chitnis XA; O'Daly O; Jones DK; Frangou S; Williams SC; Howard RJ; Barker GJ; Murray RM; McGuire P
Am J Psychiatry; 2007 Mar; 164(3):467-73. PubMed ID: 17329472
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
[TBL] [Abstract][Full Text] [Related]
12. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study.
Nasrallah HA; Skinner TE; Schmalbrock P; Robitaille PM
Br J Psychiatry; 1994 Oct; 165(4):481-5. PubMed ID: 7804662
[TBL] [Abstract][Full Text] [Related]
14. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B
Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.
Rowland L; Bustillo JR; Lauriello J
Semin Clin Neuropsychiatry; 2001 Apr; 6(2):121-30. PubMed ID: 11296312
[TBL] [Abstract][Full Text] [Related]
16. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
17. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
[TBL] [Abstract][Full Text] [Related]
18. Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy.
Lundbom N; Gaily E; Vuori K; Paetau R; Liukkonen E; Rajapakse JC; Valanne L; Häkkinen AM; Granström ML
Epilepsia; 2001 Dec; 42(12):1507-14. PubMed ID: 11879360
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
Lim KO; Adalsteinsson E; Spielman D; Sullivan EV; Rosenbloom MJ; Pfefferbaum A
Arch Gen Psychiatry; 1998 Apr; 55(4):346-52. PubMed ID: 9554430
[TBL] [Abstract][Full Text] [Related]
20. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy.
Omori M; Murata T; Kimura H; Koshimoto Y; Kado H; Ishimori Y; Ito H; Wada Y
Psychiatry Res; 2000 May; 98(3):155-62. PubMed ID: 10821998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
